https://m2.mtmt.hu/ hun 2026-10-25 06:19 JournalArticle 36934363 APPROVED true WoS:hiba:001660529000001 2026-05-18 00:53 kötet nem egyezik, füzet nem egyezik, első oldal nem egyezik 0 false 2026-09-14T17:18:48.020+0000 2026-09-04T08:41:43.633+0000 2026-02-09T20:10:11.495+0000 true 10078456 Szegedi István /api/author/10078456 Author Szegedi István (Neurológia) true 2026-09-04T08:41:43.850+0000 2026-09-04T08:41:43.850+0000 true true true 24 24 /api/publicationtype/24 PublicationType Folyóiratcikk 1 true 24 JournalArticle true 10000059 Article true 24 24 /api/publicationtype/24 PublicationType Folyóiratcikk 1 true 24 JournalArticle /api/subtype/10000059 Szakcikk SubType Szakcikk (Folyóiratcikk) 101 true 10000059 true 1 /api/category/1 Category Tudományos true 1 Szegedi, István true true /api/journal/10032890 REVIEWED NEUROLOGY AND THERAPY 2193-8253 2193-6536 true false 10032890 false 10032890 true 2193-8253 2193-6536 Journal FOREIGN - - Online ahead of print. Online ahead of print. 2026 true 2026 true true true false true false GOLD 2026-09-14 false https://www.springer.com/journal/40120 2 0 2 1 1 2 2 1 2 2 2 1 1 1 1 0 2 1 2 1 0 2 2 Folyóiratcikk Journal Article 24 2 Könyvrészlet Chapter in Book 25 0 Könyv Book 23 0 Egyéb konferenciaközlemény Conference paper 31 0 Egyéb konferenciakötet Conference proceedings 32 0 Oltalmi formák Protection forms 26 0 Disszertáció Thesis 28 0 Egyéb Miscellaneous 29 0 Alkotás Achievement 22 0 Kutatási adat Research data 33 0 Folyóiratcikk Journal Article 24 0 0 0 Könyvrészlet Chapter in Book 25 0 0 0 Könyv Book 23 0 0 0 Egyéb konferenciaközlemény Conference paper 31 0 0 0 Egyéb konferenciakötet Conference proceedings 32 0 0 0 Oltalmi formák Protection forms 26 0 0 0 Disszertáció Thesis 28 0 0 0 Egyéb Miscellaneous 29 0 0 0 Alkotás Achievement 22 0 0 0 Kutatási adat Research data 33 0 0 0 2026 0 2 1 2 1 Q1 false 10037330 false false false 2026-05-10T19:10:25.188+0000 Egészségügyi Informatikai Tanszék (DE / ETK / EgTudInt); HUN-REN-DE Cerebrovaszkuláris Kutatócsoport (DE / ÁOK); Klinikai Laboratóriumi Kutató Tanszék (DE / ÁOK / LMI); MTA-DE Lendület Hemosztázis és Stroke Kutatócso... (DE / ÁOK); Neurológiai Tanszék (DE / ÁOK) 4 23 5 4 0 true Language 10002 /api/language/10002 Angol Angol English true 2 true PersonAuthorship 133909860 /api/authorship/133909860 Szegedi, István [Szegedi, István (Neurológia), szerző] Neurológiai Tanszék (DE / ÁOK); MTA-DE Lendület Hemosztázis és Stroke Kutatócso... (DE / ÁOK) 1 0.25 true false false Author 10078456 /api/author/10078456 Szegedi István (Neurológia) Szegedi István true true Szegedi István true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 133909861 /api/authorship/133909861 Éles, Zsolt Barnabás [Éles, Zsolt Barnabás (Mikrobiológia - v...), szerző] Klinikai Laboratóriumi Kutató Tanszék (DE / ÁOK / LMI); MTA-DE Lendület Hemosztázis és Stroke Kutatócso... (DE / ÁOK) 2 0.25 false false false Author 10077098 /api/author/10077098 Éles Zsolt Barnabás (Mikrobiológia - virológia) Éles Zsolt Barnabás true true Éles Zsolt Barnabás true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 133909862 /api/authorship/133909862 Nagy, Attila [Nagy, Attila Csaba (Népegészségügy, e...), szerző] Egészségügyi Informatikai Tanszék (DE / ETK / EgTudInt); MTA-DE Lendület Hemosztázis és Stroke Kutatócso... (DE / ÁOK) 3 0.25 false false false Author 10024687 /api/author/10024687 Nagy Attila Csaba (Népegészségügy, epidemiológia) Nagy Attila Csaba true 10024687 true Nagy Attila true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 133909863 /api/authorship/133909863 Bagoly, Zsuzsa ✉ [Bagoly, Zsuzsa (Klinikai orvostud...), szerző] Klinikai Laboratóriumi Kutató Tanszék (DE / ÁOK / LMI); HUN-REN-DE Cerebrovaszkuláris Kutatócsoport (DE / ÁOK); MTA-DE Lendület Hemosztázis és Stroke Kutatócso... (DE / ÁOK) 4 0.25 false true true Author 10037330 /api/author/10037330 Bagoly Zsuzsa (Klinikai orvostudományok) Bagoly Zsuzsa true 10037330 true Bagoly Zsuzsa true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PublicationIdentifier 31391210 /api/publicationidentifier/31391210 DOI: 10.1007/s40120-025-00881-0 PlainSource 6 /api/publicationsource/6 DOI PublicationSourceType 10001 /api/publicationsourcetype/10001 DOI true true true DOI DOI https://doi.org/@@@ true true 6 true IDENTICAL 10.1007/s40120-025-00881-0 https://doi.org/10.1007/s40120-025-00881-0 false true PublicationIdentifier 31391212 /api/publicationidentifier/31391212 WoS: 001660529000001 PlainSource 1 /api/publicationsource/1 WoS PublicationSourceType 10003 /api/publicationsourcetype/10003 Indexelő adatbázis false true true WoS WoS https://www.webofscience.com/wos/woscc/full-record/@@@ true true 1 true IDENTICAL 001660529000001 https://www.webofscience.com/wos/woscc/full-record/001660529000001 false true PublicationIdentifier 31460099 /api/publicationidentifier/31460099 Scopus: 105027531510 PlainSource 3 /api/publicationsource/3 Scopus PublicationSourceType 10003 /api/publicationsourcetype/10003 Indexelő adatbázis false true true Scopus Scopus http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-@@@ true true 3 true 105027531510 http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-105027531510 false true PublicationIdentifier 31460098 /api/publicationidentifier/31460098 PubMed: 41530495 PlainSource 17 /api/publicationsource/17 PubMed PublicationSourceType 10003 /api/publicationsourcetype/10003 Indexelő adatbázis false true true PubMed PubMed http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=@@@&dopt=Abstract true true 17 true 41530495 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=41530495&dopt=Abstract false true PublicationIdentifier 31391211 /api/publicationidentifier/31391211 Egyéb URL: https://link.springer.com/10.1007/s40120-025-00881-0 PlainSource 40 /api/publicationsource/40 Egyéb URL PublicationSourceType 10006 /api/publicationsourcetype/10006 Link true true true Egyéb URL Other URL @@@ true true 40 true https://link.springer.com/10.1007/s40120-025-00881-0 https://link.springer.com/10.1007/s40120-025-00881-0 false true SjrRating 11708008 /api/sjrrating/11708008 sjr:Q1 (2026) Scopus - Neurology (clinical) NEUROLOGY AND THERAPY 2193-8253 2193-6536 67 0.24 journal RatingType 10002 /api/ratingtype/10002 sjr sjr true true ClassificationExternal 2728 /api/classificationexternal/2728 Scopus - Neurology (clinical) true 2728 true Q1 FROM_LAST_YEAR true true Reference 72278427 /api/reference/72278427 1. Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2019;50(12):e344–418., DOI: 10.1161/STR.0000000000000211 1 10.1161/STR.0000000000000211 false true Reference 72278428 /api/reference/72278428 2. Pacinella G, Ciaccio AM, Tuttolomondo A. Molecular links and clinical effects of inflammation and metabolic background on ischemic stroke: an update review. J Clin Med. 2024. https://doi.org/10.3390/jcm13247515., DOI: 10.3390/jcm13247515 2 10.3390/jcm13247515 false true Reference 72278429 /api/reference/72278429 3. Xie L, He M, Ying C, Chu H. Mechanisms of inflammation after ischemic stroke in brain-peripheral crosstalk. Front Mol Neurosci. 2024;17:1400808., DOI: 10.3389/fnmol.2024.1400808 3 10.3389/fnmol.2024.1400808 false true Reference 72278430 /api/reference/72278430 4. Bi Y, Shen J, Chen SC, Chen JX, Xia YP. Prognostic value of neutrophil to lymphocyte ratio in acute ischemic stroke after reperfusion therapy. Sci Rep. 2021;11(1):6177., DOI: 10.1038/s41598-021-85373-5 4 10.1038/s41598-021-85373-5 false true Reference 72278431 /api/reference/72278431 5. Zhang J, Ren Q, Song Y, He M, Zeng Y, Liu Z, et al. Prognostic role of neutrophil–lymphocyte ratio in patients with acute ischemic stroke. Medicine Baltimore. 2017;96(45):e8624., DOI: 10.1097/MD.0000000000008624 5 10.1097/MD.0000000000008624 false true Reference 72278432 /api/reference/72278432 6. Sharma D, Bhaskar SMM. Prognostic role of the platelet-lymphocyte ratio in acute ischemic stroke patients undergoing reperfusion therapy: a meta-analysis. J Cent Nerv Syst Dis. 2022;14:11795735221110372., DOI: 10.1177/11795735221110373 6 10.1177/11795735221110373 false true Reference 72278433 /api/reference/72278433 7. Arboix A, Alio J. Cardioembolic stroke: clinical features, specific cardiac disorders and prognosis. Curr Cardiol Rev. 2010;6(3):150–61., DOI: 10.2174/157340310791658730 7 10.2174/157340310791658730 false true Reference 72278434 /api/reference/72278434 8. Pujadas Capmany R, Arboix A, Casanas-Munoz R, Anguera-Ferrando N. Specific cardiac disorders in 402 consecutive patients with ischaemic cardioembolic stroke. Int J Cardiol. 2004;95(2–3):129–34., DOI: 10.1016/j.ijcard.2003.02.007 8 10.1016/j.ijcard.2003.02.007 false true Reference 72278435 /api/reference/72278435 9. Wang L, Song Q, Wang C, Wu S, Deng L, Li Y, et al. Neutrophil to lymphocyte ratio predicts poor outcomes after acute ischemic stroke: a cohort study and systematic review. J Neurol Sci. 2019;406:116445., DOI: 10.1016/j.jns.2019.116445 9 10.1016/j.jns.2019.116445 false true Reference 72278436 /api/reference/72278436 10. Yan YK, Huang H, Li DP, Ai ZY, Li X, Sun Z. Prognostic value of the platelet-to-lymphocyte ratio for outcomes of stroke: a systematic review and meta-analysis. Eur Rev Med Pharmacol Sci. 2021;25(21):6529–38. 10 false true Reference 72278437 /api/reference/72278437 11. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097., DOI: 10.1371/journal.pmed.1000097 11 10.1371/journal.pmed.1000097 false true Reference 72278438 /api/reference/72278438 12. van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke. 1988;19(5):604–7., DOI: 10.1161/01.STR.19.5.604 12 10.1161/01.STR.19.5.604 false true Reference 72278439 /api/reference/72278439 13. García-Berrocoso T, Giralt D, Bustamante A, Etgen T, Jensen JK, Sharma JC, et al. B-type natriuretic peptides and mortality after stroke: a systematic review and meta-analysis. Neurology. 2013;81(23):1976–85., DOI: 10.1212/01.wnl.0000436937.32410.32 13 10.1212/01.wnl.0000436937.32410.32 false true Reference 72278440 /api/reference/72278440 14. Aly M, Abdalla RN, Batra A, Shaibani A, Hurley MC, Jahromi BS, et al. Follow-up neutrophil–lymphocyte ratio after stroke thrombectomy is an independent biomarker of clinical outcome. J Neurointerv Surg. 2021;13(7):609–13., DOI: 10.1136/neurintsurg-2020-016342 14 10.1136/neurintsurg-2020-016342 false true Reference 72278441 /api/reference/72278441 15. Aytaç E, Balgetir F, Genç ŞK, Gönen M, Dogan H, Akpinar CK. Effect of inflammatory response before mechanical thrombectomy on prognosis in stroke patients. Ideggyogy Sz. 2024;77(9–10):323–7., DOI: 10.18071/isz.77.0323 15 10.18071/isz.77.0323 false true Reference 72278442 /api/reference/72278442 16. Bartt R, Sercy E, Pirahanchi Y, Frei D, Bar-Or D. Associations of neutrophil–lymphocyte ratios with reperfusion and functional outcomes in ischemic stroke after endovascular therapy. J Stroke Cerebrovasc Dis. 2022. https://doi.org/10.1016/j.jstrokecerebrovasdis.2022.106843., DOI: 10.1016/j.jstrokecerebrovasdis.2022.106843 16 10.1016/j.jstrokecerebrovasdis.2022.106843 false true Reference 72278443 /api/reference/72278443 17. Brooks SD, Spears C, Cummings C, VanGilder RL, Stinehart KR, Gutmann L, et al. Admission neutrophil–lymphocyte ratio predicts 90 day outcome after endovascular stroke therapy. J Neurointerv Surg. 2014;6(8):578–83., DOI: 10.1136/neurintsurg-2013-010780 17 10.1136/neurintsurg-2013-010780 false true Reference 72278444 /api/reference/72278444 18. Cao W, Song Y, Bai X, Yang B, Li L, Wang X, et al. Systemic-inflammatory indices and clinical outcomes in patients with anterior circulation acute ischemic stroke undergoing successful endovascular thrombectomy. Heliyon. 2024. https://doi.org/10.1016/j.heliyon.2024.e31122., DOI: 10.1016/j.heliyon.2024.e31122 18 10.1016/j.heliyon.2024.e31122 false true Reference 72278445 /api/reference/72278445 19. Du M, Xu L, Zhang X, Jiang H, Huang X, Cao H, et al. Association between inflammatory burden index and unfavorable prognosis after endovascular thrombectomy in acute ischemic stroke. J Inflamm Res. 2023;16:3009–17., DOI: 10.2147/JIR.S419087 19 10.2147/JIR.S419087 false true Reference 72278446 /api/reference/72278446 20. Duan ZH, Wang HM, Wang Z, Hao YG, Zi WJ, Yang D, et al. Neutrophil–lymphocyte ratio predicts functional and safety outcomes after endovascular treatment for acute ischemic stroke. Cerebrovasc Dis. 2018;45(5–6):221–7., DOI: 10.1159/000489401 20 10.1159/000489401 false true Reference 72278447 /api/reference/72278447 21. Eren A, Giray S. Value of the red blood cell distribution width (RDW) and neutrophil lymphocyte ratio (NLR) in the prediction of functional recovery and 3-month mortality following endovascular treatment for acute anterior circulation ischemic stroke. Heliyon. 2024. https://doi.org/10.1016/j.heliyon.2024.e38030., DOI: 10.1016/j.heliyon.2024.e38030 21 10.1016/j.heliyon.2024.e38030 false true Reference 72278448 /api/reference/72278448 22. Feng Y, Bai X, Li W, Cao W, Xu X, Yu F, et al. Postoperative neutrophil–lymphocyte ratio predicts unfavorable outcome of acute ischemic stroke patients who achieve complete reperfusion after thrombectomy. Front Immunol. 2022. https://doi.org/10.3389/fimmu.2022.963111., DOI: 10.3389/fimmu.2022.963111 22 10.3389/fimmu.2022.963111 false true Reference 72278449 /api/reference/72278449 23. Goyal N, Tsivgoulis G, Chang JJ, Malhotra K, Pandhi A, Ishfaq MF, et al. Admission neutrophil-to-lymphocyte ratio as a prognostic biomarker of outcomes in large vessel occlusion strokes. Stroke. 2018;49(8):1985–7., DOI: 10.1161/STROKEAHA.118.021477 23 10.1161/STROKEAHA.118.021477 false true Reference 72278450 /api/reference/72278450 24. Guan JC, Wang Q, Zhao QS. Lymphocyte to monocyte ratio is independently associated with futile recanalization in acute ischemic stroke after endovascular therapy. Neuropsychiatr Dis Treat. 2023;19:2585–96., DOI: 10.2147/NDT.S434225 24 10.2147/NDT.S434225 false true Reference 72278451 /api/reference/72278451 25. Kim H, Kim JT, Choi KH, Yoon W, Baek BH, Kim SK, et al. Futile recanalization after endovascular treatment in acute ischemic stroke with large ischemic core. BMC Neurol. 2024. https://doi.org/10.1186/s12883-024-03912-9., DOI: 10.1186/s12883-024-03912-9 25 10.1186/s12883-024-03912-9 false true Reference 72278452 /api/reference/72278452 26. Li R, Yin Y, Cai X, Zhu Y, Feng S, Sun J, et al. Effect of routine inflammatory markers on clinical outcomes in acute basilar artery occlusion after endovascular thrombectomy: Results from ATTENTION registry. Int J Stroke. 2023;18(8):976–85., DOI: 10.1177/17474930231176948 26 10.1177/17474930231176948 false true Reference 72278453 /api/reference/72278453 27. Li SJ, Cao SS, Huang PS, Nie X, Fu Y, Liu JR. Post-operative neutrophil-to-lymphocyte ratio and outcome after thrombectomy in acute ischemic stroke. Front Neurol. 2022. https://doi.org/10.3389/fneur.2022.990209., DOI: 10.3389/fneur.2022.990209 27 10.3389/fneur.2022.990209 false true Reference 72278454 /api/reference/72278454 28. Li XB, Wu F, Jiang C, Feng XK, Wang R, Song ZW, et al. Novel peripheral blood cell ratios: effective 3-month post-mechanical thrombectomy prognostic biomarkers for acute ischemic stroke patients. J Clin Neurosci. 2021;89:56–64., DOI: 10.1016/j.jocn.2021.04.013 28 10.1016/j.jocn.2021.04.013 false true Reference 72278455 /api/reference/72278455 29. Liao MF, Li FL, Hu JR, Yang J, Wu DP, Xie DJ, et al. High neutrophil counts before endovascular treatment for acute basilar artery occlusion predict worse outcomes. Front Aging Neurosci. 2022. https://doi.org/10.3389/fnagi.2022.978740., DOI: 10.3389/fnagi.2022.978740 29 10.3389/fnagi.2022.978740 false true Reference 72278456 /api/reference/72278456 30. Liao J, Guo C, Zhang B, Yang J, Zi W, Li J. Low neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios predict favorable outcomes after endovascular treatment in acute basilar artery occlusion: subgroup analysis of the BASILAR registry. BMC Neurol. 2023. https://doi.org/10.1186/s12883-023-03161-2., DOI: 10.1186/s12883-023-03161-2 30 10.1186/s12883-023-03161-2 false true Reference 72278457 /api/reference/72278457 31. Ma J, Guo WT, Xu JL, Li SJ, Ren CH, Wu LF, et al. Association of platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio with outcomes in stroke patients achieving successful recanalization by endovascular thrombectomy. Front Neurol. 2022. https://doi.org/10.3389/fneur.2022.1039060., DOI: 10.3389/fneur.2022.1039060 31 10.3389/fneur.2022.1039060 false true Reference 72278458 /api/reference/72278458 32. Oh SW, Yi HJ, Lee DH, Sung JH. Prognostic significance of various inflammation-based scores in patients with mechanical thrombectomy for acute ischemic stroke. World Neurosurg. 2020;141:e710–7., DOI: 10.1016/j.wneu.2020.05.272 32 10.1016/j.wneu.2020.05.272 false true Reference 72278459 /api/reference/72278459 33. Ozdogru D, Uysal OK, Erdem M, Soker EB, Ozturk I, Avci A, et al. Fibrinogen to albumin ratio’s prognostic value in ischemic stroke patients who underwent mechanical thrombectomy. Ideggyogy Sz. 2024. https://doi.org/10.18071/isz.77.0167., DOI: 10.18071/isz.77.0167 33 10.18071/isz.77.0167 false true Reference 72278460 /api/reference/72278460 34. Ozgen E, Guzel M, Akpinar CK, Yucel M, Demir MT, Baydin A. The relationship between neutrophil/lymphocyte, monocyte//lymphocyte, platelet/lymphocyte ratios and clinical outcomes after ninety days in patients who were diagnosed as having acute ischemic stroke in the emergency room and underwent a mechanical thrombectomy. Bratisl Med J. 2020;121(9):634–9., DOI: 10.4149/BLL_2020_102 34 10.4149/BLL_2020_102 false true Reference 72278461 /api/reference/72278461 35. Pincáková K, Krastev G, Haring J, Mako M, Mikulásková V, Bosák V. Low lymphocyte-to-monocyte ratio as a possible predictor of an unfavourable clinical outcome in patients with acute ischemic stroke after mechanical thrombectomy. Stroke Res Treat. 2022;2022(2022):9243080. https://doi.org/10.1155/2022/9243080., DOI: 10.1155/2022/9243080 35 10.1155/2022/9243080 false true Reference 72278462 /api/reference/72278462 36. Semerano A, Laredo C, Zhao Y, Rudilosso S, Renu A, Llull L, et al. Leukocytes, collateral circulation, and reperfusion in ischemic stroke patients treated with mechanical thrombectomy. Stroke. 2019;50(12):3456–64., DOI: 10.1161/STROKEAHA.119.026743 36 10.1161/STROKEAHA.119.026743 false true Reference 72278463 /api/reference/72278463 37. Sun D, Huo X, Jia B, Tong X, Wang A, Ma G, et al. Endovascular treatment for acute ischaemic stroke due to medium vessel occlusion: data from ANGEL-ACT registry. Stroke Vasc Neurol. 2023;8(1):51–8., DOI: 10.1136/svn-2022-001561 37 10.1136/svn-2022-001561 false true Reference 72278464 /api/reference/72278464 38. Sun DP, Yang XG, Huo XC, Jia BX, Tong X, Wang AX, et al. Incidence and predictors of futile recanalisation after endovascular therapy in acute vertebrobasilar artery occlusion patients: insight from the ANGEL-ACT registry. Stroke Vasc Neurol. 2024;9(3):289–94., DOI: 10.1136/svn-2022-002185 38 10.1136/svn-2022-002185 false true Reference 72278465 /api/reference/72278465 39. Wang H, Tian XB, Liao ZY, Yue XY, Sun LB, Li XR, et al. Inflammatory biomarkers may be associated with poor outcomes after mechanical thrombectomy. Thromb J. 2024. https://doi.org/10.1186/s12959-024-00630-7., DOI: 10.1186/s12959-024-00630-7 39 10.1186/s12959-024-00630-7 false true Reference 72278466 /api/reference/72278466 40. Wang HM, Zhang M, Hao YG, Zi WJ, Yang D, Zhou ZM, et al. Early prediction of poor outcome despite successful recanalization after endovascular treatment for anterior large vessel occlusion stroke. World Neurosurg. 2018;115:E312–21., DOI: 10.1016/j.wneu.2018.04.042 40 10.1016/j.wneu.2018.04.042 false true Reference 72278467 /api/reference/72278467 41. Wang LR, Li BH, Zhang Q, Cheng XD, Jia LJ, Zhou S, et al. Predictors of futile recanalization after endovascular treatment of acute ischemic stroke. BMC Neurol. 2024. https://doi.org/10.1186/s12883-024-03719-8., DOI: 10.1186/s12883-024-03719-8 41 10.1186/s12883-024-03719-8 false true Reference 72278468 /api/reference/72278468 42. Yi HJ, Sung JH, Lee DH. Systemic inflammation response index and systemic immune-inflammation index are associated with clinical outcomes in patients treated with mechanical thrombectomy for large artery occlusion. World Neurosurg. 2021;153:e282–9., DOI: 10.1016/j.wneu.2021.06.113 42 10.1016/j.wneu.2021.06.113 false true Reference 72278469 /api/reference/72278469 43. Zhang P, Xu P, Duan Z, Zhang F, Fang Y, Yan D, et al. Effects of admission systemic inflammatory indicators on clinical outcomes in patients with vertebrobasilar artery occlusion: insight from the PERSIST registry. J Neurointerv Surg. 2023;15(e2):E270–6., DOI: 10.1136/jnis-2022-019437 43 10.1136/jnis-2022-019437 false true Reference 72278470 /api/reference/72278470 44. Altintas O, Altintas MO, Tasal A, Kucukdagli OT, Asil T. The relationship of platelet-to-lymphocyte ratio with clinical outcome and final infarct core in acute ischemic stroke patients who have undergone endovascular therapy. Neurol Res. 2016;38(9):759–65., DOI: 10.1080/01616412.2016.1215030 44 10.1080/01616412.2016.1215030 false true Reference 72278471 /api/reference/72278471 45. Kim SY, Yi HJ, Shin DS, Kim BT. Prognostic significance of platelet-to-lymphocyte and platelet-to-neutrophil ratios in patients with mechanical thrombectomy for acute ischemic stroke. J Cerebrovasc Endovasc Neurosurg. 2022;24(3):221–31., DOI: 10.7461/jcen.2022.E2021.10.003 45 10.7461/jcen.2022.E2021.10.003 false true Reference 72278472 /api/reference/72278472 46. Wang L, Cheng Q, Peng M, Lv D, Zi W, Xu G, et al. The relationship between the platelet to leukocyte ratio and mechanical thrombectomy outcomes in acute ischemic stroke patients. Neurol Res. 2020. https://doi.org/10.1080/01616412.2020.1790868., DOI: 10.1080/01616412.2020.1790868 46 10.1080/01616412.2020.1790868 false true Reference 72278473 /api/reference/72278473 47. Chen CT, Li LH, Su PY, Chang YC, Lee IH, Yen DHT, et al. Neutrophil-to-lymphocyte ratio in predicting neurologic outcome of patients with acute ischemic stroke treated with intravenous thrombolytics. J Chin Med Assoc. 2022;85(1):102–8., DOI: 10.1097/JCMA.0000000000000599 47 10.1097/JCMA.0000000000000599 false true Reference 72278474 /api/reference/72278474 48. Chu YW, Chen PY, Lin SK. Correlation between immune-inflammatory markers and clinical features in patients with acute ischemic stroke. Acta Neurol Taiwan. 2020;29(4):103–13. 48 false true Reference 72278475 /api/reference/72278475 49. Li LZ, Han ZP, Wang RL, Fan JF, Zheng YM, Huang YY, et al. Association of admission neutrophil serine proteinases levels with the outcomes of acute ischemic stroke: a prospective cohort study. J Neuroinflamm. 2023. https://doi.org/10.1186/s12974-023-02758-1., DOI: 10.1186/s12974-023-02758-1 49 10.1186/s12974-023-02758-1 false true Reference 72278476 /api/reference/72278476 50. Li Y, Li L, Qie T. Developing a nomogram model for 3-month prognosis in patients who had an acute ischaemic stroke after intravenous thrombolysis: a multifactor logistic regression model approach. BMJ Open. 2024. https://doi.org/10.1136/bmjopen-2023-079428., DOI: 10.1136/bmjopen-2023-079428 50 10.1136/bmjopen-2023-079428 false true Reference 72278477 /api/reference/72278477 51. Liu YL, Wu ZQ, Qu JF, Qiu DH, Luo GP, Yin HP, et al. High neutrophil-to-lymphocyte ratio is a predictor of poor short-term outcome in patients with mild acute ischemic stroke receiving intravenous thrombolysis. Brain Behav. 2020. https://doi.org/10.1002/brb3.1857., DOI: 10.1002/brb3.1857 51 10.1002/brb3.1857 false true Reference 72278478 /api/reference/72278478 52. Maestrini I, Strbian D, Gautier S, Haapaniemi E, Moulin S, Sairanen T, et al. Higher neutrophil counts before thrombolysis for cerebral ischemia predict worse outcomes. Neurology. 2015;85(16):1408–16., DOI: 10.1212/WNL.0000000000002029 52 10.1212/WNL.0000000000002029 false true Reference 72278479 /api/reference/72278479 53. Malhotra K, Goyal N, Chang JJ, Broce M, Pandhi A, Kerro A, et al. Differential leukocyte counts on admission predict outcomes in patients with acute ischaemic stroke treated with intravenous thrombolysis. Eur J Neurol. 2018;25(12):1417–24., DOI: 10.1111/ene.13741 53 10.1111/ene.13741 false true Reference 72278480 /api/reference/72278480 54. Pagram H, Bivard A, Lincz LF, Levi C. Peripheral immune cell counts and advanced imaging as biomarkers of stroke outcome. Cerebrovasc Dis Extra. 2016;6(3):120–8., DOI: 10.1159/000450620 54 10.1159/000450620 false true Reference 72278481 /api/reference/72278481 55. Pan H, Fu M, Ge WQ, Zhou CY. The effects of changes in platelet-to-neutrophil ratios 24 hours after intravenous thrombolysis on prognosis in acute ischemic stroke patients. Clin Neurol Neurosurg. 2020. https://doi.org/10.1016/j.clineuro.2020.105739., DOI: 10.1016/j.clineuro.2020.105739 55 10.1016/j.clineuro.2020.105739 false true Reference 72278482 /api/reference/72278482 56. Pektezel MY, Yilmaz E, Arsava EM, Topcuoglu MA. Neutrophil-to-lymphocyte ratio and response to intravenous thrombolysis in patients with acute ischemic stroke. J Stroke Cerebrovasc Dis. 2019;28(7):1853–9., DOI: 10.1016/j.jstrokecerebrovasdis.2019.04.014 56 10.1016/j.jstrokecerebrovasdis.2019.04.014 false true Reference 72278483 /api/reference/72278483 57. Qian K, Hu J, Wang C, Xu C, Chen Y, Feng Q, et al. Dynamic change of neutrophil-to-lymphocyte ratio and its predictive value of prognosis in acute ischemic stroke. Brain Behav. 2024. https://doi.org/10.1002/brb3.3616., DOI: 10.1002/brb3.3616 57 10.1002/brb3.3616 false true Reference 72278484 /api/reference/72278484 58. Shahin MA, Melake MS, Ibrahim SS, Hamdey AMED. Prognostic value of neutrophil /lymphocyte ratio in acute ischemic stroke patients either received reperfusion therapy or not. Egypt J Hosp Med. 2021;84(1):1662–6., DOI: 10.21608/ejhm.2021.175179 58 10.21608/ejhm.2021.175179 false true Reference 72278485 /api/reference/72278485 59. Shi J, Peng H, You S, Liu Y, Xu J, Xu Y, et al. Increase in neutrophils after recombinant tissue plasminogen activator thrombolysis predicts poor functional outcome of ischaemic stroke: a longitudinal study. Eur J Neurol. 2018;25(4):687-e45., DOI: 10.1111/ene.13575 59 10.1111/ene.13575 false true Reference 72278486 /api/reference/72278486 60. Weng Y, Hu J, Ren J, Huang H, Yang C, Shen J, et al. Dynamic neutrophil–lymphocyte ratios predict short-term prognostic outcome of thrombolysis in patients with acute ischemic stroke. Neurotoxic Res. 2021;39(5):1678–87., DOI: 10.1007/s12640-021-00382-6 60 10.1007/s12640-021-00382-6 false true Reference 72278487 /api/reference/72278487 61. Wu Q, Chen HS. Neutrophil-to-lymphocyte ratio and its changes predict the 3-month outcome and mortality in acute ischemic stroke patients after intravenous thrombolysis. Brain Behav. 2023. https://doi.org/10.1002/brb3.3162., DOI: 10.1002/brb3.3162 61 10.1002/brb3.3162 false true Reference 72278488 /api/reference/72278488 62. Xie J, Pang C, Yu H, Zhang W, Ren C, Deng B. Leukocyte indicators and variations predict worse outcomes after intravenous thrombolysis in patients with acute ischemic stroke. J Cereb Blood Flow Metab. 2023;43(3):393–403., DOI: 10.1177/0271678X221142694 62 10.1177/0271678X221142694 false true Reference 72278489 /api/reference/72278489 63. Ying AN, Cheng YN, Lin YY, Yu JR, Wu XY, Lin YS. Dynamic increase in neutrophil levels predicts parenchymal hemorrhage and function outcome of ischemic stroke with r-tPA thrombolysis. Neurol Sci. 2020;41(8):2215–23., DOI: 10.1007/s10072-020-04324-6 63 10.1007/s10072-020-04324-6 false true Reference 72278490 /api/reference/72278490 64. Zhang TR, Fu S, Cao XF, Xia YJY, Hu MY, Feng QH, et al. Correlation of peripheral blood inflammatory indicators to prognosis after intravenous thrombolysis in acute ischemic stroke: a retrospective study. Int J Gen Med. 2024;17:985–96., DOI: 10.2147/IJGM.S456144 64 10.2147/IJGM.S456144 false true Reference 72278491 /api/reference/72278491 65. Zhao FF, Wang RL, Huang YY, Li LZ, Zhong LY, Hu Y, et al. Elevated plasma syndecan-1 as glycocalyx injury marker predicts unfavorable outcomes after rt-PA intravenous thrombolysis in acute ischemic stroke. Front Pharmacol. 2022. https://doi.org/10.3389/fphar.2022.949290., DOI: 10.3389/fphar.2022.949290 65 10.3389/fphar.2022.949290 false true Reference 72278492 /api/reference/72278492 66. Sun YY, Wang MQ, Wang Y, Sun X, Qu Y, Zhu HJ, et al. Platelet-to-lymphocyte ratio at 24h after thrombolysis is a prognostic marker in acute ischemic stroke patients. Front Immunol. 2022. https://doi.org/10.3389/fimmu.2022.1000626., DOI: 10.3389/fimmu.2022.1000626 66 10.3389/fimmu.2022.1000626 false true Reference 72278493 /api/reference/72278493 67. Yao Y, Cao X, Zou R, Wen H, Zhang S, Xu H, et al. Study on the baseline factors and platelet indices that predict outcome of acute ischemic stroke patients after thrombolytic therapy. Cerebrovasc Dis. 2022;51(3):357–64., DOI: 10.1159/000519705 67 10.1159/000519705 false true Reference 72278494 /api/reference/72278494 68. Wang MQ, Sun YY, Wang Y, Yan XL, Jin H, Sun X, et al. Platelet-to-neutrophil ratio after intravenous thrombolysis predicts unfavorable outcomes in acute ischemic stroke. Curr Neurovasc Res. 2020;17(4):411–9., DOI: 10.2174/1567202617666200517111802 68 10.2174/1567202617666200517111802 false true Reference 72278495 /api/reference/72278495 69. Ren H, Han L, Liu HB, Wang L, Liu X, Gao YJ. Decreased lymphocyte-to-monocyte ratio predicts poor prognosis of acute ischemic stroke treated with thrombolysis. Med Sci Monit. 2017;23:5826–33., DOI: 10.12659/MSM.907919 69 10.12659/MSM.907919 false true Reference 72278496 /api/reference/72278496 70. Sadeghi F, Sarkady F, Zsóri KS, Szegedi I, Orbán-Kálmándi R, Székely EG, et al. High neutrophil–lymphocyte ratio and low lymphocyte–monocyte ratio combination after thrombolysis is a potential predictor of poor functional outcome of acute ischemic stroke. J Pers Med. 2022. https://doi.org/10.3390/jpm12081221., DOI: 10.3390/jpm12081221 70 10.3390/jpm12081221 false true Reference 72278497 /api/reference/72278497 71. Rexrode KM, Madsen TE, Yu AYX, Carcel C, Lichtman JH, Miller EC. The impact of sex and gender on stroke. Circ Res. 2022;130(4):512–28., DOI: 10.1161/CIRCRESAHA.121.319915 71 10.1161/CIRCRESAHA.121.319915 false true Reference 72278498 /api/reference/72278498 72. Russo T, Felzani G, Marini C. Stroke in the very old: a systematic review of studies on incidence, outcome, and resource use. J Aging Res. 2011;2011:108785., DOI: 10.4061/2011/108785 72 10.4061/2011/108785 false true Reference 72278499 /api/reference/72278499 73. Planas AM. Role of immune cells migrating to the ischemic brain. Stroke. 2018;49(9):2261–7., DOI: 10.1161/STROKEAHA.118.021474 73 10.1161/STROKEAHA.118.021474 false true Reference 72278500 /api/reference/72278500 74. Candelario-Jalil E, Dijkhuizen RM, Magnus T. Neuroinflammation, stroke, blood-brain barrier dysfunction, and imaging modalities. Stroke. 2022;53(5):1473–86., DOI: 10.1161/STROKEAHA.122.036946 74 10.1161/STROKEAHA.122.036946 false true Reference 72278501 /api/reference/72278501 75. Guo P, Li H, Zhang X, Liu Y, Xue S, Yong VW, et al. Matrix metalloproteinase‑9 in hemorrhagic transformation after acute ischemic stroke (review). Mol Med Rep. 2025. https://doi.org/10.3892/mmr.2025.13590., DOI: 10.3892/mmr.2025.13590 75 10.3892/mmr.2025.13590 false true Reference 72278502 /api/reference/72278502 76. Qiu YM, Zhang CL, Chen AQ, Wang HL, Zhou YF, Li YN, et al. Immune cells in the BBB disruption after acute ischemic stroke: targets for immune therapy? Front Immunol. 2021;12:678744., DOI: 10.3389/fimmu.2021.678744 76 10.3389/fimmu.2021.678744 false true Reference 72278503 /api/reference/72278503 77. Turner RJ, Sharp FR. Implications of MMP9 for blood brain barrier disruption and hemorrhagic transformation following ischemic stroke. Front Cell Neurosci. 2016;10:56., DOI: 10.3389/fncel.2016.00056 77 10.3389/fncel.2016.00056 false true Reference 72278504 /api/reference/72278504 78. Meisel C, Schwab JM, Prass K, Meisel A, Dirnagl U. Central nervous system injury-induced immune deficiency syndrome. Nat Rev Neurosci. 2005;6(10):775–86., DOI: 10.1038/nrn1765 78 10.1038/nrn1765 false true Reference 72278505 /api/reference/72278505 79. Haeusler KG, Schmidt WU, Fohring F, Meisel C, Helms T, Jungehulsing GJ, et al. Cellular immunodepression preceding infectious complications after acute ischemic stroke in humans. Cerebrovasc Dis. 2008;25(1–2):50–8., DOI: 10.1159/000111499 79 10.1159/000111499 false true Reference 72278506 /api/reference/72278506 80. Liu DD, Chu SF, Chen C, Yang PF, Chen NH, He X. Research progress in stroke-induced immunodepression syndrome (SIDS) and stroke-associated pneumonia (SAP). Neurochem Int. 2018;114:42–54., DOI: 10.1016/j.neuint.2018.01.002 80 10.1016/j.neuint.2018.01.002 false true Reference 72278507 /api/reference/72278507 81. Vogelgesang A, Grunwald U, Langner S, Jack R, Broker BM, Kessler C, et al. Analysis of lymphocyte subsets in patients with stroke and their influence on infection after stroke. Stroke. 2008;39(1):237–41., DOI: 10.1161/STROKEAHA.107.493635 81 10.1161/STROKEAHA.107.493635 false true Reference 72278508 /api/reference/72278508 82. Bendszus M, Fiehler J, Subtil F, Bonekamp S, Aamodt AH, Fuentes B, et al. Endovascular thrombectomy for acute ischaemic stroke with established large infarct: multicentre, open-label, randomised trial. Lancet. 2023;402(10414):1753–63., DOI: 10.1016/S0140-6736(23)02032-9 82 10.1016/S0140-6736(23)02032-9 false true Reference 72278509 /api/reference/72278509 83. Sarraj A, Hassan AE, Abraham MG, Ortega-Gutierrez S, Kasner SE, Hussain MS, et al. Trial of endovascular thrombectomy for large ischemic strokes. N Engl J Med. 2023;388(14):1259–71., DOI: 10.1056/NEJMoa2214403 83 10.1056/NEJMoa2214403 false true Reference 72278510 /api/reference/72278510 84. Choi KH, Kim JH, Kang KW, Kim JT, Choi SM, Lee SH, et al. HbA1c (glycated hemoglobin) levels and clinical outcome post-mechanical thrombectomy in patients with large vessel occlusion. Stroke. 2019;50(1):119–26., DOI: 10.1161/STROKEAHA.118.021598 84 10.1161/STROKEAHA.118.021598 false true Reference 72278511 /api/reference/72278511 85. Heiss WD, Kidwell CS. Imaging for prediction of functional outcome and assessment of recovery in ischemic stroke. Stroke. 2014;45(4):1195–201., DOI: 10.1161/STROKEAHA.113.003611 85 10.1161/STROKEAHA.113.003611 false true Reference 72278512 /api/reference/72278512 86. Zhang W, Xing W, Lin W, Liu Y, He X, Wen Y, et al. Plasma D-dimer can predict all-cause mortality after mechanical thrombectomy of anterior circulation noncardioembolic acute cerebral infarction. Langenbecks Arch Surg. 2025;410(1):60., DOI: 10.1007/s00423-025-03614-x 86 10.1007/s00423-025-03614-x false true /api/publication/36934363 Szegedi István et al. Venous Blood Cell Ratios as Predictors of Reperfusion Outcomes in Ischemic Stroke: A Systematic Review and Meta-analysis. (2026) NEUROLOGY AND THERAPY 2193-8253 2193-6536 - - p. Online ahead of print.<div class="JournalArticle Publication long-list"> <div class="authors"> <img title="Forrásközlemény" style="float: left" src="/frontend/resources/grid/publication-core-icon.png"> <img title="Idézőközlemény" style="float: left" src="/frontend/resources/grid/publication-citation-icon.png"> <div class="autype autype0"> <span class="author-name" mtid="10078456"><a href="/gui2/?type=authors&mode=browse&sel=10078456" target="_blank">Szegedi István (<span class="authorship-author-name">Szegedi István</span> <span class="authorAux-mtmt"> Neurológia</span>) </a> </span> <span class="author-affil"><span title="Debreceni Egyetem">DE</span>/<span title="Általános Orvostudományi Kar">ÁOK</span>/Neurológiai Tanszék; <span title="Debreceni Egyetem">DE</span>/<span title="Általános Orvostudományi Kar">ÁOK</span>/MTA-DE Lendület Hemosztázis és Stroke Kutatócsoport</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10077098"><a href="/gui2/?type=authors&mode=browse&sel=10077098" target="_blank">Éles Zsolt Barnabás (<span class="authorship-author-name">Éles Zsolt Barnabás</span> <span class="authorAux-mtmt"> Mikrobiológia - virológia</span>) </a> </span> <span class="author-affil"><span title="Debreceni Egyetem">DE</span>/<span title="Általános Orvostudományi Kar">ÁOK</span>/<span title="Laboratóriumi Medicina Intézet">LMI</span>/Klinikai Laboratóriumi Kutató Tanszék; <span title="Debreceni Egyetem">DE</span>/<span title="Általános Orvostudományi Kar">ÁOK</span>/MTA-DE Lendület Hemosztázis és Stroke Kutatócsoport</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10024687"><a href="/gui2/?type=authors&mode=browse&sel=10024687" target="_blank">Nagy Attila (<span class="authorship-author-name">Nagy Attila Csaba</span> <span class="authorAux-mtmt"> Népegészségügy, epidemiológia</span>) </a> </span> <span class="author-affil"><span title="Debreceni Egyetem">DE</span>/<span title="Egészségtudományi Kar">ETK</span>/<span title="Egészségtudományi Intézet">EgTudInt</span>/Egészségügyi Informatikai Tanszék; <span title="Debreceni Egyetem">DE</span>/<span title="Általános Orvostudományi Kar">ÁOK</span>/MTA-DE Lendület Hemosztázis és Stroke Kutatócsoport</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10037330"><a href="/gui2/?type=authors&mode=browse&sel=10037330" target="_blank">Bagoly Zsuzsa ✉ (<span class="authorship-author-name">Bagoly Zsuzsa</span> <span class="authorAux-mtmt"> Klinikai orvostudományok</span>) </a> </span> <span class="author-affil"><span title="Debreceni Egyetem">DE</span>/<span title="Általános Orvostudományi Kar">ÁOK</span>/<span title="Laboratóriumi Medicina Intézet">LMI</span>/Klinikai Laboratóriumi Kutató Tanszék; <span title="Debreceni Egyetem">DE</span>/<span title="Általános Orvostudományi Kar">ÁOK</span>/HUN-REN-DE Cerebrovaszkuláris Kutatócsoport; <span title="Debreceni Egyetem">DE</span>/<span title="Általános Orvostudományi Kar">ÁOK</span>/MTA-DE Lendület Hemosztázis és Stroke Kutatócsoport</span> </div> </div> <div class="title"><a href="/gui2/?mode=browse&params=publication;36934363" target="_blank">Venous Blood Cell Ratios as Predictors of Reperfusion Outcomes in Ischemic Stroke: A Systematic Review and Meta-analysis</a></div> <div> <span class="journal-title">NEUROLOGY AND THERAPY</span> <span class="journal-issn">(<a target="_blank" href="https://portal.issn.org/resource/ISSN/2193-8253">2193-8253</a> <a target="_blank" href="https://portal.issn.org/resource/ISSN/2193-6536">2193-6536</a>)</span>: <span class="journal-volume">-</span> <span class="journal-issue">-</span> <span class="page"> p. Online ahead of print.. </span> <span class="year">(2026)</span> </div> <div class="pub-footer"> <span class="language" xmlns="http://www.w3.org/1999/html">Nyelv: Angol | </span> <span class="identifiers"> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="10.1007/s40120-025-00881-0" target="_blank" href="https://doi.org/10.1007/s40120-025-00881-0"> DOI </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="001660529000001" target="_blank" href="https://www.webofscience.com/wos/woscc/full-record/001660529000001"> WoS </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:black" title="105027531510" target="_blank" href="http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-105027531510"> Scopus </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:black" title="41530495" target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=41530495&dopt=Abstract"> PubMed </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:black" title="https://link.springer.com/10.1007/s40120-025-00881-0" target="_blank" href="https://link.springer.com/10.1007/s40120-025-00881-0"> Egyéb URL </a> </span> </span> <OnlyViewableByAuthor><div class="ratings"> <div class="journal-subject">Folyóirat szakterülete: Scopus - Neurology (clinical)&nbsp;&nbsp;&nbsp;SJR indikátor:&nbsp;Q1</div> <div class="journal-subject">Folyóirat szakterülete: Scopus - Neurology&nbsp;&nbsp;&nbsp;SJR indikátor:&nbsp;Q1</div> </div></OnlyViewableByAuthor> <div class="publication-citation" style="margin-left: 0.5cm;"> <span title="Nyilvános idézőközlemények összesen, említések nélkül" class="citingPub-count">Nyilvános idéző összesen: 2</span> | Független: 1 | Függő: 1 | Nem jelölt: 0 | WoS jelölt: 1 | Scopus jelölt:&nbsp;2 | WoS/Scopus jelölt:&nbsp;2 | DOI jelölt:&nbsp;2 </div> <div class="publication-citation"> <a target="_blank" href="/api/publication?cond=citations.related;eq;36934363&sort=publishedYear,desc&sort=title"> Idézett közlemények száma: 2 </a> </div> <div class="mtid"><span class="long-pub-mtid">Közlemény: 36934363</span> | <span class="status-data status-APPROVED"> Nyilvános </span> Forrás Idéző | <span class="type-subtype">Folyóiratcikk ( Szakcikk ) </span> | <span class="pub-category">Tudományos</span> | <span class="publication-sourceOfData">WoS-XML</span> </div> <div class="lastModified">Utolsó módosítás: 2026.09.04. 10:41 Csűry-Bagaméry Beáta (DE/ÁOK/LMI/KLKT admin5) </div> <pre class="comment" style="margin-top: 0; margin-bottom: 0;"><u>Megjegyzés</u>: WoS:hiba:001660529000001 2026-05-18 00:53 kötet nem egyezik, füzet nem egyezik, első oldal nem egyezik</pre> </div></div>